Fact CheckerSign in

NCT06059521Recruiting

Software Refraction With Mobilerone Versus Retinoscopy

Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy

Source: ClinicalTrials.gov · Last updated 28 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
24 Jul 2023
Start date
15 Jul 2023
Primary completion date
30 Dec 2025
Lead sponsor
Beijing Airdoc Technology Co., Ltd.
NCT number
NCT06059521

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 15 Jul 2023 to the primary completion date, 30 Dec 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • • subject with a topography showing an anomaly (keratoconus type or other)
    • subject with hyperopia or presbyopia
    • subject with mild myopia ≥ -1.00D
    • subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists

Who the study is looking for

  • • subject with ametropia on each eye ≤-12.00D
    • subject with best corrected visual acuity ≥ 20/25, no amblyopia
    • subject with normal transparency of eyes
    • subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
    • subject able to cooperate with the screen and the operator
    • subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
    • non-diabetic subject
    • non nystagmus subject
    • non-strabismus subject
    • subject who has not had eye surgery less than 1 year old

Age in the registry: 10 years to 46 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Airdoc MPC Opthalmology Clinics
Coordinator of this site? Confirm its status
BeijingChinaNot yet recruiting
Jenny QIU
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Qiu Jenny
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.